Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis.

MLA

Lee, Kyoungmin, et al. “Systemic HD-MTX for CNS Prophylaxis in High-Risk DLBCL Patients: A Prospectively Collected, Single-Center Cohort Analysis.” International Journal of Hematology, vol. 110, no. 1, July 2019, pp. 86–94. EBSCOhost, https://doi.org/10.1007/s12185-019-02653-7.

APA

Lee, K., Yoon, D. H., Hong, J. Y., Kim, S., Kang, E. H., Huh, J., Park, C.-S., Lee, S. W., & Suh, C. (2019). Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis. International Journal of Hematology, 110(1), 86–94. https://doi.org/10.1007/s12185-019-02653-7

Chicago

Lee, Kyoungmin, Dok Hyun Yoon, Jung Yong Hong, Shin Kim, Eun Hee Kang, Jooryung Huh, Chan-Sik Park, Sang Wook Lee, and Cheolwon Suh. 2019. “Systemic HD-MTX for CNS Prophylaxis in High-Risk DLBCL Patients: A Prospectively Collected, Single-Center Cohort Analysis.” International Journal of Hematology 110 (1): 86–94. doi:10.1007/s12185-019-02653-7.